Canal Capital Management’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$377K Buy
4,117
+5
+0.1% +$437 0.05% 164
2026
Q1
$350K Buy
4,112
+5
+0.1% +$446 0.05% 156
2025
Q4
$325K Sell
4,107
-88
-2% -$6.9K 0.05% 151
2025
Q3
$335K Sell
4,195
-52
-1% -$4.44K 0.05% 144
2025
Q2
$386K Hold
4,247
– – 0.06% 132
2025
Q1
$398K Sell
4,247
-35
-0.8% -$3.13K 0.07% 116
2024
Q4
$389K Hold
4,282
– – 0.06% 125
2024
Q3
$445K Hold
4,282
– – 0.07% 109
2024
Q2
$416K Buy
4,282
+190
+5% +$17.5K 0.07% 108
2024
Q1
$368K Sell
4,092
-190
-4% -$16.1K 0.06% 114
2023
Q4
$341K Hold
4,282
– – 0.06% 125
2023
Q3
$304K Hold
4,282
– – 0.06% 117
2023
Q2
$330K Hold
4,282
– – 0.07% 116
2023
Q1
$322K Buy
+4,282
New +$318K 0.07% 119
2020
Q2
– Sell
-4,955
Closed -$329K – 109
2020
Q1
$329K Buy
+4,955
New +$349K 0.19% 83

Other funds holding CL

Canal Capital Management's CL Position: Q2 2026 in Review

Canal Capital Management increased its Colgate-Palmolive (CL) stake by 0.12% in Q2 2026, buying an estimated $437 and bringing the position to 4,117 shares worth $377K. The position accounts for 0.05% of the portfolio, ranked #164.

Canal Capital Management first reported a position in CL in Q1 2020 and has held it in 15 quarters since. The position peaked at $445K in Q3 2024. 2,028 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Canal Capital Management held 4,117 shares of Colgate-Palmolive worth $377K as of Q2 2026.
  • Canal Capital Management bought 5 Colgate-Palmolive shares in Q2 2026, an estimated $437.
  • Colgate-Palmolive made up 0.05% of Canal Capital Management's portfolio in Q2 2026, its #164 holding.
  • Canal Capital Management first reported a position in Colgate-Palmolive in Q1 2020 and has held it in 15 quarters since.
  • Canal Capital Management's Colgate-Palmolive position peaked at $445K in Q3 2024.
  • 2,028 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Canal Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.